Latest Paliperidone Stories
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
Results served as basis for regulatory filing with U.S.
TITUSVILLE, N.J., Jan. 19, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
As off-label antipsychotic use is mounting so, too, is litigation associated with specific atypical antipsychotics Port Washington, New York (PRWEB) January
The Firm is currently representing numerous men and boys in Risperdal lawsuits that also allege the drug caused gynecomastia, a condition marked by the excessive breast growth in male patients.
The Firm is representing numerous clients who have filed Risperdal lawsuits after allegedly developing gynecomastia, or male breast growth, due to the antipsychotic medication. New
First Long-Acting Treatment to be Used Four Times a Year for Schizophrenia in Adults TITUSVILLE, N.J., Nov.
JANSSEN® CONNECT® program seeks to provide people living with schizophrenia information and assistance to support healthcare provider-ordered long-acting antipsychotic treatment TITUSVILLE,
Submission based on first head-to-head study vs. oral treatments in real world context TITUSVILLE, N.J., July 14, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc.
- A serpent whose bite was fabled to produce intense thirst.